Beta‐blockers for suspected or diagnosed acute myocardial infarction
Referencias
Additional references
Ahlquist RP. A study of the adrenotropic receptors. American Journal of Physiology 1948;153(3):586‐600. [PUBMED: 18882199]
Al‐Reesi A, Al‐Zadjali N, Perry J, Fergusson D, Al‐Shamsi M, Al‐Thagafi M, et al. Do beta‐blockers reduce short‐term mortality following acute myocardial infarction? A systematic review and meta‐analysis. CJEM 2008;10(3):215‐23. [PUBMED: 19019272]
Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST‐Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2014;64(24):e139‐228.
Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative beta blockers in patients having non‐cardiac surgery: a meta‐analysis. Lancet 2008;372(9654):1962‐76. [PUBMED: 19012955]
Bangalore S, Makani H, Radford M, Thakur K, Toklu B, Katz SD, et al. Clinical outcomes with beta‐blockers for myocardial infarction: a meta‐analysis of randomized trials. American Journal of Medicine 2014;127(10):939‐53. [PUBMED: 24927909]
Black JW, Crowther AF, Shanks RG, Smith LH, Dornhorst AC. A new adrenergic betareceptor antagonist. Lancet 1964;1(7342):1080‐1. [PUBMED: 14132613]
Brandler E, Paladino L, Sinert R. Does the early administration of beta‐blockers improve the in‐hospital mortality rate of patients admitted with acute coronary syndrome?. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 2010;17(1):1‐10. [PUBMED: 20078433]
Brieger D, Fox KA, Fitzgerald G, Eagle KA, Budaj A, Avezum A, et al. Predicting freedom from clinical events in non‐ST‐elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart (British Cardiac Society) 2009;95(11):888‐94.
Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology 2008;61(8):763‐9.
Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta‐analyses may be inconclusive. Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology 2009;38(1):287‐98.
Campeau L. Letter: Grading of angina pectoris. Circulation 1976;54(3):522‐3. [PUBMED: 947585]
Chatterjee S, Chaudhuri D, Vedanthan R, Fuster V, Ibanez B, Bangalore S, et al. Early intravenous beta‐blockers in patients with acute coronary syndrome ‐ a meta‐analysis of randomized trials. International Journal of Cardiology 2013;168(2):915‐21. [PUBMED: 23168009]
Chatterjee S, Biondi‐Zoccai G, Abbate A, D'Ascenzo F, Castagno D, Van Tassell B, et al. Benefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta‐analysis. BMJ 2013;346:f55. [PUBMED: 23325883]
Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo‐controlled trial. Lancet 2005;366(9497):1622‐32. [PUBMED: 16271643]
Clausen J, Felsby M, Jorgensen FS, Nielsen BL, Roin J, Strange B. Absence of prophylactic effect of propranolol in myocardial infarction. Lancet 1966;2(7470):920‐4. [PUBMED: 4162366]
Cooper R, Cutler J, Desvigne‐Nickens P, Fortmann SP, Friedman L, Havlik R, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation2000; Vol. 102, issue 25:3137‐47. [PUBMED: 11120707]
Copenhagen Trial Unit (CTU). Trial Sequential Analysis (TSA). Version 0.9.5.5 beta. Copenhagen: Copenhagen Trial Unit (CTU), 2011.
DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341‐50. [PUBMED: 3616287]
DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88. [PUBMED: 3802833]
Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al. Effects of extended‐release metoprolol succinate in patients undergoing non‐cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371(9627):1839‐47.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34.
Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999;318(7200):1730‐7. [PUBMED: 10381708]
Friedman LM, Byington RP, Capone RJ, Furberg CD, Goldstein S, Lichstein E. Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia. Journal of the American College of Cardiology 1986;7(1):1‐8. [PUBMED: 3510232]
Gluud LL. Bias in clinical intervention research. American Journal of Epidemiology 2006;163(6):493‐501.
Golan DE, Tashjian AH. Principles of Pharmacology ‐ The Pathophysiologic Basis of Drug Therapy. 3rd Edition. Philadelphia: Lippincott Williams and Wilkins, 2011.
Greenblatt DJ, Koch‐Weser J. Adverse reactions to beta‐adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program. Drugs 1974;7(1):118‐29. [PUBMED: 4151696]
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck‐Ytter Y, Alonso‐Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924‐6. [PUBMED: 18436948]
Harbord RM, Egger M, Sterne JA. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443‐57. [PUBMED: 16345038]
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistenty in meta‐analyses. BMJ 2003;327(7414):557‐60.
Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins JP, Whitehead A, Simmonds M. Sequential methods for random‐effects meta‐analysis. Statistics in Medicine 2011;30(9):903‐21. [PUBMED: 21472757]
Houston MC. Abrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome. American Heart Journal 1981;102(3 Pt 1):415‐30. [PUBMED: 6115570]
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts Consolidated Guideline on Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use. International Digest of Health Legislation1997; Vol. 48, issue 2:231‐4. [PUBMED: 11656783]
Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta‐analytic methods. BMC Medical Research Methodology 2014;14:120. [PUBMED: 25416419]
Juul AB, Wetterslev J, Gluud C, Kofoed‐Enevoldsen A, Jensen G, Callesen T, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non‐cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 2006;332(7556):1482. [PUBMED: 16793810]
Keus F, Wetterslev J, Gluud C, van Laarhoven CJ. Evidence at a glance: error matrix approach for overviewing available evidence. BMC Medical Research Methodology 2010;10:90. [DOI: 10.1186/1471‐2288‐10‐90]
Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9.
Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta‐blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002;288(3):351‐7. [PUBMED: 12117400]
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Lloyd‐Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: heart disease and stroke statistics ‐ 2010 update: a report from the American Heart Association. Circulation 2010;121(7):948‐54. [PUBMED: 20177011]
Lopez‐Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, et al. Expert consensus document on beta‐adrenergic receptor blockers. European Heart Journal 2004;25(15):1341‐62. [PUBMED: 15288162]
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2]
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 2013;34(28):2159‐219.
Marlin GE, Kumana CR, Kaye CM, Smith DM, Turner P. An investigation into the cardiac and pulmonary beta‐adrenoceptor blocking activity of ICI 66,082 in man. British Journal of Clinical Pharmacology 1975;2(2):151‐7. [PUBMED: 1234497]
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352(9128):609‐13.
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal 2013;34(38):2949‐3003.
Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. European Heart Journal 2014;35(42):2950‐9. [PUBMED: 25139896]
O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST‐elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2013;61(4):e78‐140.
Pogue JM, Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta‐analysis. Controlled Clinical Trials 1997;18(6):580‐93; discussion 661‐6. [PUBMED: 9408720]
Pohjola‐Sintonen S, Muller JE, Stone PH, Willich SN, Antman EM, Davis VG, et al. Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. American Heart Journal 1989;117(4):809‐18.
Quirke V. Putting theory into practice: James Black, receptor theory and the development of the beta‐blockers at ICI, 1958‐1978. Medical History 2006;50(1):69‐92.
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST‐segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST‐Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal 2016;37(3):267‐315.
Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics ‐ 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117(4):e25‐146. [PUBMED: 18086926]
Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591‐603.
Rücker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta‐analyses with binary outcomes. Statistics in Medicine 2008;27(5):746‐63. [PUBMED: 17592831]
Savovic J, Jones HE, Altman DG, Harris RJ, Juni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157(6):429‐38.
Savovic J, Jones H, Altman D, Harris R, Juni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta‐epidemiological studies. Health Technology Assesment 2012;16(35):1‐82.
Schmidt M, Jacobsen JB, Lash TL, Botker HE, Sorensen HT. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ 2012;344:e356. [PUBMED: 22279115]
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12.
Singh BN, Nisbet HE, Harris EA, Whitlock RM. A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta‐adrenoceptors. European Journal of Pharmacology 1975;34(1):75‐86. [PUBMED: 11998]
StataCorp LP. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP http://www.stata.com 2014. College Station, TX: StataCorp LP, 2015.
Steg PG, James SK, Atar D, Badano LP, Blomstrom‐Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST‐segment elevation. European Heart Journal 2012;33(20):2569‐619. [PUBMED: 22922416]
Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393. [PUBMED: 19564179]
Stevenson WG, Linssen GC, Havenith MG, Brugada P, Wellens HJ. The spectrum of death after myocardial infarction: a necropsy study. American Heart Journal 1989;118(6):1182‐8.
Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data. Statistics in Medicine 2004;23(9):1351‐75. [PUBMED: 15116347]
Taylor SH, Silke B, Lee PS. Intravenous beta‐blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?. New England Journal of Medicine 1982;306(11):631‐5. [PUBMED: 6120457]
Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al. Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine 2006;21(1):30‐8.
Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?. International Journal of Epidemiology 2009;38(1):276‐86.
Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). www.ctu.dk/tsa/files/tsa_manual.pdf (accessed prior to 5 December 2016).
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Global Heart 2012;7(4):275‐95. [PUBMED: 25689940]
Turner SM, Beidel DC, Jacob RG. Social phobia: a comparison of behavior therapy and atenolol. Journal of Consulting and Clinical Psychology 1994;62(2):350‐8. [PUBMED: 8201073]
Turner RM, Bird SM, Higgins JP. The impact of study size on meta‐analyses: examination of underpowered studies in Cochrane reviews. PloS One 2013;8(3):e59202. [PUBMED: 23544056]
Waal HJ. Propranolol‐induced depression. BMJ 1967;2(5543):50. [PUBMED: 6021004]
Ware JEJ, Sherbourne CD. The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473‐83.
Warren SC, Warren SG. Propranolol and sexual impotence. Annals of Internal Medicine1977; Vol. 86, issue 1:112. [PUBMED: 835912]
Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology 2008;61(1):64‐75.
Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology 2009;9:86.
World Health Organization (WHO). Cardiovascular disease. www.who.int/cardiovascular_diseases/en/ (accessed prior to 5 December 2016).
Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH. Beta‐blockers for hypertension. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD002003.pub4]
Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ 2008;336(7644):601‐5.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DEJ, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;128:e240‐e327.
Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases 1985;27(5):335‐71. [PUBMED: 2858114]
